Moua Pachai, Checketts Mathew, Xu Liang-Guo, Shu Hong-Bing, Reyland Mary E, Cusick John K
California Northstate University, College of Pharmacy, 9700 West Taron Drive, Elk Grove, CA, USA.
University of Colorado School of Dental Medicine, Department of Craniofacial Biology, University of Colorado Anschutz Medical Campus, 12801 East 17th Avenue, Aurora, CO 80045, USA.
Biochem Biophys Res Commun. 2017 Sep 9;491(1):25-32. doi: 10.1016/j.bbrc.2017.07.022. Epub 2017 Jul 5.
Receptor Expressed in Lymphoid Tissues (RELT) is a human Tumor Necrosis Factor Receptor (TNFR) family member that has two identified homologous binding partners, RELL1 and RELL2. This study sought to further understand the pattern of RELT expression, the functional role of RELT family members, and the mechanism of RELT-induced apoptosis. RELT protein expression was detected in the spleen, lymph node, brain, breast and peripheral blood leukocytes (PBLs). A smaller than expected size of RELT was observed in PBLs, suggesting a proteolytically cleaved form of RELT. RELL1 and RELL2 overexpression activated the p38 MAPK pathway more substantially than RELT in HEK-293 cells, and this activation of p38 by RELT family members was blocked by dominant-negative mutant forms of OSR1 or TRAF2, implicating these molecules in RELT family member signaling. RELT was previously shown to induce apoptosis in human epithelial cells despite lacking the characteristic death domain (DD) found in other TNFRs. Seven deletion mutants of RELT that lacked differing portions of the intracellular domain were created to assess whether RELT possesses a novel DD. None of the deletion mutants induced apoptosis as efficiently as full-length RELT, a result that is consistent with a novel DD being located at the carboxyl-terminus. Interestingly, induction of apoptotic morphology by RELT overexpression was not prevented when signaling by FADD or Caspase-8 was blocked, indicating RELT induces apoptosis by a pathway distinct from other death-inducing TNFRs such as TNFR1. Collectively, this study provides more insights into RELT expression, RELT family member function, and the mechanism of RELT-induced death.
淋巴组织中表达的受体(RELT)是一种人类肿瘤坏死因子受体(TNFR)家族成员,已确定有两个同源结合伴侣,即RELL1和RELL2。本研究旨在进一步了解RELT的表达模式、RELT家族成员的功能作用以及RELT诱导凋亡的机制。在脾脏、淋巴结、脑、乳腺和外周血白细胞(PBL)中检测到了RELT蛋白表达。在PBL中观察到RELT的大小比预期小,提示存在一种经蛋白水解切割的RELT形式。在HEK-293细胞中,RELL1和RELL2的过表达比RELT更显著地激活p38丝裂原活化蛋白激酶(MAPK)途径,并且RELT家族成员对p38的这种激活被OSR1或TRAF2的显性负性突变体形式所阻断,这表明这些分子参与了RELT家族成员的信号传导。先前研究表明,尽管RELT缺乏其他TNFR中发现的特征性死亡结构域(DD),但它仍可诱导人上皮细胞凋亡。构建了七个缺失细胞内不同区域的RELT缺失突变体,以评估RELT是否具有新的DD。没有一个缺失突变体诱导凋亡的效率与全长RELT一样高,这一结果与新的DD位于羧基末端一致。有趣的是,当FADD或半胱天冬酶-8的信号传导被阻断时,RELT过表达诱导的凋亡形态并未受到阻止,这表明RELT通过一条不同于其他诱导死亡的TNFR(如TNFR1)的途径诱导凋亡。总的来说,本研究为RELT的表达、RELT家族成员的功能以及RELT诱导死亡的机制提供了更多见解。